Abstract
In Australia, in recent years, there have been a number of news reports of patients
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ärztekammer Nordrhein [AEKNO]. (2016). Comment regarding the commercial application of adult stem cells. https://www.aekno.de/page.asp?pageID=7460. Accessed 26 Feb 2016.
Brown, P., & Calnan, M. (2010). Braving a faceless new world? Conceptualising trust in the pharmaceutical industry and its products. Health, 16(1), 57–75.
Castel, R. (1991). From dangerousness to risk. In G. Burchell, C. Gordan, & P. Miller (Eds.), The Foucault effect: Studies in governmentality (pp. 281–298). Hemel Hempstead: Harvester Wheatsheaf.
Copelan, E. A. (2006). Hematopoietic stem-cell transplantation. New England Journal of Medicine, 354(17), 1813–1826.
Daley, G. (2012). The promise and perils of stem cell therapeutics. Cell Stem Cell, 10(6), 740–749.
European Medicines Agency. (2013, April 22). Stem cell therapy treatments. http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/04/news_detail_001769.jsp&mid=WC0b01ac058004d5c1. Accessed 4 July 2015.
Giddens, A. (1991). Modernity and self-identity: Self and society in the late modern age. Cambridge: Polity.
Luhmann, N. (1988). Familiarity, confidence, trust: Problems and alternatives. In D. Gambetta (Ed.), Trust: Making and breaking cooperative relations (pp. 94–108). Oxford: Basil Blackwell.
MacGregor, C., Petersen, A., & Munsie, M. (2015, December 13). Patient access to unproven stem cell treatments: A human rights issue? Eurostemcell. http://www.eurostemcell.org/commentanalysis/patient-access-unproven-stem-cell-treatments-human-rights-issue. Accessed 4 Mar 2016.
Medicinal Products Act - The Drug Law. (2012). Arzneimittelgesetz – AMG. Bundesministerium der Justiz und für Verbraucherschutz/juris GmbH. Federal Republic of Germany. http://www.gesetze-im-internet.de/englisch_amg/. Accessed 9 Mar 2016.
Mendick, R. (2012, April 7). Stem cell doctor forced to close his clinic after child’s death is back in business. The Telegraph. http://www.telegraph.co.uk/news/health/news/9192216/Stem-cell-doctor-forced-to-close-his-clinic-after-childs-death-is-back-in-business.html. Accessed 4 Apr 2016.
MÓ§llering, G. (2006). Trust: Reason, routine, reflexivity. Oxford: Elsevier.
Rettig, R. A., Jacobson, P. D., Farquhar, C., & Aubry, W. M. (2007). False hope: Bone marrow transplantation for breast cancer. Oxford: Oxford University Press.
Schnitger, A. (2014). The hospital exemption: A regulatory option for unauthorised advanced therapy medicinal products. Unpublished master’s thesis, University of Bonn.
Tuffs, A. (2007). Thalidomide—The drama continues. British Medical Journal, 335, 1125.
X-Cell Center. (2008). The miracles from Dusseldorf and Cologne. http://web.archive.org/web/20080512193510/http://www.xcell-center.com/news190a.html?id=17. Accessed 12 May 2008.
Author information
Authors and Affiliations
Copyright information
© 2017 The Author(s)
About this chapter
Cite this chapter
Petersen, A., Munsie, M., Tanner, C., MacGregor, C., Brophy, J. (2017). Exploiting Stem Cell Hopes in Germany. In: Stem Cell Tourism and the Political Economy of Hope. Health, Technology and Society. Palgrave Macmillan, London. https://doi.org/10.1057/978-1-137-47043-0_5
Download citation
DOI: https://doi.org/10.1057/978-1-137-47043-0_5
Published:
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-137-47042-3
Online ISBN: 978-1-137-47043-0
eBook Packages: Social SciencesSocial Sciences (R0)